Q2 EPS Estimates for Acadia Healthcare Cut by Zacks Research

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Stock analysts at Zacks Research cut their Q2 2025 earnings estimates for shares of Acadia Healthcare in a report released on Wednesday, July 16th. Zacks Research analyst R. Sipani now forecasts that the company will post earnings of $0.68 per share for the quarter, down from their previous forecast of $0.69. The consensus estimate for Acadia Healthcare's current full-year earnings is $3.38 per share. Zacks Research also issued estimates for Acadia Healthcare's Q3 2025 earnings at $0.86 EPS, Q4 2025 earnings at $0.70 EPS, FY2025 earnings at $2.65 EPS, Q1 2026 earnings at $0.47 EPS, Q2 2026 earnings at $0.75 EPS, FY2026 earnings at $2.92 EPS and FY2027 earnings at $3.37 EPS.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. Acadia Healthcare had a net margin of 5.94% and a return on equity of 8.72%. The firm had revenue of $770.51 million during the quarter, compared to the consensus estimate of $769.90 million. During the same quarter in the previous year, the firm posted $0.84 EPS. The business's revenue for the quarter was up .3% compared to the same quarter last year.

Other equities research analysts have also recently issued reports about the stock. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Barclays decreased their price objective on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Mizuho decreased their price objective on shares of Acadia Healthcare from $37.00 to $32.00 and set a "neutral" rating for the company in a research report on Wednesday, May 14th. Stephens upgraded shares of Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Finally, Guggenheim assumed coverage on shares of Acadia Healthcare in a research note on Wednesday, April 9th. They set a "buy" rating and a $36.00 target price on the stock. Five analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $47.94.

Acadia Healthcare Price Performance

ACHC stock traded down $0.28 during trading on Friday, reaching $21.64. 1,462,552 shares of the company were exchanged, compared to its average volume of 1,869,107. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.35 and a quick ratio of 1.35. Acadia Healthcare has a twelve month low of $20.36 and a twelve month high of $82.41. The company has a 50-day moving average of $23.07 and a two-hundred day moving average of $30.06. The company has a market capitalization of $1.99 billion, a price-to-earnings ratio of 10.66, a P/E/G ratio of 4.18 and a beta of 0.93.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Wellington Management Group LLP increased its position in Acadia Healthcare by 0.7% during the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company's stock valued at $465,283,000 after purchasing an additional 76,490 shares during the period. FMR LLC boosted its holdings in shares of Acadia Healthcare by 257.9% during the 4th quarter. FMR LLC now owns 6,230,631 shares of the company's stock valued at $247,045,000 after buying an additional 4,489,681 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Acadia Healthcare by 18.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company's stock valued at $126,189,000 after buying an additional 486,395 shares in the last quarter. Hawk Ridge Capital Management LP boosted its stake in Acadia Healthcare by 437.5% in the 1st quarter. Hawk Ridge Capital Management LP now owns 2,473,226 shares of the company's stock worth $74,988,000 after purchasing an additional 2,013,126 shares in the last quarter. Finally, Citigroup Inc. boosted its stake in Acadia Healthcare by 5,144.2% in the 1st quarter. Citigroup Inc. now owns 2,376,209 shares of the company's stock worth $72,047,000 after purchasing an additional 2,330,898 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.